This salient observation that EHop-097 is a Vav/Rac specific inhibitor demonstrates its utility in inhibiting specific cancer cells, as well as immune cells, where the Vav1/Rac2 activation is central to immune cell function (50). Here, VAV1 is linked to cancer.